Vanguard Group’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.4M | Sell |
|
|||||
|
2025
Q1 | $21.4M | Sell |
|
|||||
|
2024
Q4 | $18.7M | Sell |
|
|||||
|
2024
Q3 | $20.3M | Buy |
|
|||||
|
2024
Q2 | $12.4M | Sell |
|
|||||
|
2024
Q1 | $12.7M | Sell |
|
|||||
|
2023
Q4 | $13.8M | Buy |
|
|||||
|
2023
Q3 | $21.3M | Buy |
|
|||||
|
2023
Q2 | $26.7M | Buy |
|
|||||
|
2023
Q1 | $24.8M | Buy |
|
|||||
|
2022
Q4 | $17.3M | Sell |
|
|||||
|
2022
Q3 | $13.4M | Buy |
|
|||||
|
2022
Q2 | $9.72M | Sell |
|
|||||
|
2022
Q1 | $13.2M | Buy |
|
|||||
|
2021
Q4 | $11.3M | Buy |
|
|||||
|
2021
Q3 | $23.9M | Buy |
|
|||||
|
2021
Q2 | $30.6M | Buy |
|
|||||
|
2021
Q1 | $24.4M | Buy |
|
|||||
|
2020
Q4 | $11.1M | Sell |
|
|||||
|
2020
Q3 | $12.2M | Buy |
|
|||||
|
2020
Q2 | $4.31M | Sell |
|
|||||
|
2020
Q1 | $2.78M | Buy |
|
|||||
|
2019
Q4 | $6.54M | Sell |
|
|||||
|
2019
Q3 | $5.95M | Buy |
|
|||||
|
2019
Q2 | $6.67M | Buy |
|
|||||
|
2019
Q1 | $9.65M | Sell |
|
|||||
|
2018
Q4 | $9.13M | Buy |
|
|||||
|
2018
Q3 | $13.1M | Buy |
|
|||||
|
2018
Q2 | $6M | Buy |
|
|||||
|
2018
Q1 | $5.23M | Sell |
|
|||||
|
2017
Q4 | $4.75M | Buy |
|
|||||
|
2017
Q3 | $3.39M | Buy |
|
|||||
|
2017
Q2 | $1.43M | Buy |
|
|||||
|
2017
Q1 | $1.48M | Buy |
|
|||||
|
2016
Q4 | $779K | Buy |
|
|||||
|
2016
Q3 | $1.04M | Buy |
|
|||||
|
2016
Q2 | $712K | Buy |
|
|||||
|
2016
Q1 | $508K | Buy |
|
|||||
|
2015
Q4 | $802K | Buy |
|
|||||
|
2015
Q3 | $626K | Buy |
|
|||||
|
2015
Q2 | $802K | Buy |
|